Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

By continuing you agree to the terms and privacy policy.

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Download on theApp StoreGet it onGoogle Play

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Live Terminal
Economy · Full coverage

Teva Pharmaceuticals Launches Major Debt Refinancing Effort After Credit Rating Upgrade

How 3 Israeli newsrooms (in Hebrew, Russian) covered this story — translated into English and compared side by side.

Unrated 3

By מנדי הניג

First reported by Mignews · 1 day ago

What happened

Teva Pharmaceuticals is refinancing over $4 billion in debt following its upgrade to investment-grade credit rating by S&P, Moody's, and Fitch. The move aims to lower borrowing costs and extend debt maturities, reflecting the company's successful debt reduction and renewed focus on growth.

  • 01Teva Pharmaceuticals is refinancing over $4 billion in debt.
  • 02The company recently regained investment-grade credit ratings.
  • 03The refinancing aims to lower interest costs and extend debt maturities.
  • 04Teva has significantly reduced its debt since 2016.
  • 05The company is also investing in growth through acquisitions.

Summary translated & synthesized from the sources below by baba. Read each original for the full report.

In this story
OrganizationsTeva Pharmaceuticals, S&P Global Ratings, Moody's, Fitch

Full coverage · 3 outlets

The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.

BizportalUnrated · Hebrew13 hours ago
Teva Pharmaceuticals Launches Major Debt Refinancing Effort After Credit Rating Upgrade
GlobesUnrated · Hebrew14 hours ago
Teva Pharmaceuticals Refinances Debt Following Credit Rating Upgrades
MignewsUnrated · Russian1 day ago
Teva Pharmaceuticals Launches New Euro and Dollar Bonds After Credit Rating Upgrade

Related stories

Teva Pharmaceutical Industries Earns Investment-Grade Credit Rating2 days agoTeva's Stock Surges as It Eyes Inclusion in S&P 500 Following Strong Q2 ResultsJul 29, 2026Teva Reports Higher-Than-Expected Q2 Revenue but Misses Profit EstimatesJul 29, 2026Teva Finance Chief Sells Nearly NIS 62 Million in Shares as Stock SurgesJun 16, 2026Teva Shares Continue Decline Amid Market Volatility and Sector ComparisonsJul 19, 2026Teva's Former Israeli-Traded Pharma Giant Perrigo Collapses After Delisting, Sparing Local Investors Heavy LossesJun 30, 2026